Open main menu
Search Ctrl + K
Free Trial
Loading...
Xeris Biopharma Holdings, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.XERS
180 N. Lasalle Street, Suite 1600, Chicago, IL, 60601
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Ownership
4
Schmid John P.
13 Aug 24
4
Schmid John P.
12 Aug 24
4
Hecht Beth
09 Aug 24
4
Johnson Kenneth Erland
09 Aug 24
4
Pieper Steven
09 Aug 24
3
Mcculloch Kevin
02 Aug 24
4
Mcculloch Kevin
02 Aug 24
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
23 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
23 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
26 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
02 May 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 22
Other
ARS
Scanned Paper Annual Report Submission.
23 Apr 24
ARS
Scanned Paper Annual Report Submission.
26 Apr 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
07 Feb 22
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
07 Feb 22
CORRESP
Correspondence With The Sec.
04 Feb 22
CORRESP
Correspondence With The Sec.
04 Feb 22
UPLOAD
Letter From The Sec.
01 Feb 22
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
02 Aug 24
8-K
Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure
08 Jul 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders
05 Jun 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
09 May 24
8-K
Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Other Events
06 Mar 24
Financials
10-Q
Quarterly Filing
08 Nov 24
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
09 May 24
10-K
Fiscal Year 2024
06 Mar 24
10-Q
Quarterly Filing
09 Nov 23
10-Q
Quarterly Filing
08 Aug 23
10-Q
Quarterly Filing
09 May 23
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
08 Aug 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
06 Mar 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
08 Mar 23
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
11 May 22
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
11 Mar 22
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
08 Feb 22
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
05 Oct 21